U.S. FDA Global Offices Update: China Approval Imminent, India On The Horizon
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA is making headway in its efforts to establish U.S. regulatory offices overseas, with final approval in China imminent and a proposal for offices in India in final stages of U.S. approval